Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


Additional Hyperbaric Oxygen After Lower Extremity Amputation
Conditions:   Diabetes Mellitus;   Claudication, Intermittent;   Critical Limb Ischemia;   Osteomyelitis;   Amputation;   Lower Extremity Ulcer;   Diabetic Angiopathy;   Diabetic Neuropathies;   Diabetic Foot
Intervention:   Procedure: Hyperbaric oxygen therapy
Sponsor:   Oslo University Hospital
Recruiting

Fri, 20 Jul 2018 12:00:00 EDT


Cardiac Sarcoidosis Randomized Trial
Conditions:   Cardiac Sarcoidosis;   Sarcoidosis
Interventions:   Drug: Prednisone;   Drug: Methotrexate
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research (CIHR)
Not yet recruiting

Fri, 20 Jul 2018 12:00:00 EDT


Changes in the Retinal and Carotid Microcirculation After Restoring Normoglycemia in Patients With Type 2 Diabetes
Conditions:   Type 2 Diabetes Mellitus;   Microangiopathy;   Diabetic Retinopathy;   Arteriosclerosis;   Carotid Atherosclerosis
Intervention:   Drug: Antidiabetic treatment by usual care
Sponsors:   Hospital Clinic of Barcelona;   Instituto de Salud Carlos III;   CIBERobn;   Institut d'Investigacions Biomèdiques August Pi i Sunyer
Recruiting

Fri, 20 Jul 2018 12:00:00 EDT


Effects of High Intensity Interval Training and Combined Training in Type 2 Diabetic (T2D) Patients
Conditions:   Diabetes Mellitus, Type 2;   High-Intensity Interval Training;   Exercise Training;   Hyperglycaemia Due to Type 2 Diabetes Mellitus
Interventions:   Other: Physical training;   Other: Light-Emitting Diode (LED) therapy
Sponsor:   University of Nove de Julho
Not yet recruiting

Fri, 20 Jul 2018 12:00:00 EDT


Effects of Metformin During Nicotine Withdrawal
Conditions:   Smoking;   HIV-1-infection
Interventions:   Drug: Metformin;   Drug: Placebo
Sponsors:   University of Pennsylvania;   Pennsylvania Department of Health
Recruiting

Fri, 20 Jul 2018 12:00:00 EDT


Group Lifestyle Balance™ for Individuals With Traumatic Brain Injury (GLB-TBI)
Condition:   Traumatic Brain Injury
Interventions:   Behavioral: Group Lifestyle Balance™;   Other: Attention Control Group
Sponsors:   Baylor Research Institute;   National Institute on Disability, Independent Living, and Rehabilitation Research;   University of Texas Southwestern Medical Center
Recruiting

Fri, 20 Jul 2018 12:00:00 EDT


Technology Delivered Diabetes-Modified Behavioral Activation Treatment
Condition:   Diabetes Mellitus, Type 2
Interventions:   Behavioral: TECH DM-BAT;   Behavioral: TECH DMBAT Active Comparator;   Behavioral: TECH DMBAT Other
Sponsor:   Medical College of Wisconsin
Recruiting

Fri, 20 Jul 2018 12:00:00 EDT


The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series
Conditions:   T1DM;   Hypersensitivity
Intervention:   Drug: Fluticasone Propionate
Sponsor:   Assaf-Harofeh Medical Center
Completed

Fri, 20 Jul 2018 12:00:00 EDT


Vitamin B Complex and Diabetic Nephropathy in Type 1 Diabetes
Conditions:   Plasma Homocysteine;   HbA1c Level
Interventions:   Drug: Vitamin B complex tablets (Neurorubine TM -Forte Lactab TM);   Dietary Supplement: Placebo
Sponsor:   Ain Shams University
Completed

Fri, 20 Jul 2018 12:00:00 EDT


Amitriptyline in Treating Hypoglycemia
Conditions:   Type1 Diabetes Mellitus;   Hypoglycemia Unawareness
Interventions:   Drug: Amitriptyline;   Drug: Placebo
Sponsor:   Yu Kuei (Alex) Lin, MD
Recruiting

Thu, 19 Jul 2018 12:00:00 EDT


Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension
Condition:   Hypertension
Interventions:   Drug: Dapagliflozin;   Drug: Placebo - Cap
Sponsor:   University of Guadalajara
Enrolling by invitation

Thu, 19 Jul 2018 12:00:00 EDT


Effect of Apple Cider Vinegar in Type 2 Diabetics
Conditions:   Randomized Controlled Trial;   Diabetes Mellitus
Interventions:   Dietary Supplement: Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group);   Other: Water with Apple Cider vinegar flavor and tablet Tagipmet (Metformin + Sitagliptin group)
Sponsor:   Sheikh Zayed Federal Postgraduate Medical Institute
Completed

Thu, 19 Jul 2018 12:00:00 EDT


Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI
Condition:   Reperfusion Injury, Myocardial
Interventions:   Drug: Empagliflozin;   Other: placebo
Sponsor:   Chinese PLA General Hospital
Not yet recruiting

Thu, 19 Jul 2018 12:00:00 EDT


Food Order Intervention for Gestational Diabetes
Condition:   Gestational Diabetes
Interventions:   Behavioral: Food Order Therapy;   Behavioral: Medical Nutrition Therapy
Sponsor:   Weill Medical College of Cornell University
Recruiting

Thu, 19 Jul 2018 12:00:00 EDT


Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients
Condition:   Lower Extremity Amputation
Intervention:   Other: Lower Extremity Amputation Pathway
Sponsor:   University of California, San Francisco
Not yet recruiting

Thu, 19 Jul 2018 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from FDA Commissioner Scott Gottlieb, M.D., on manufacturer announcement to halt Essure sales in the U.S.; agency’s continued commitment to postmarket review of Essure and keeping women informed
The FDA responds to Bayer’s announcement to halt Essure sales in the US

Fri, 20 Jul 2018 12:59:00 -0400


FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
FDA approves new drug for the treatment of adults with acute myeloid leukemia who have a specific genetic mutation and a companion diagnostic to detect specific mutations in the IDH1 gene in patients with AML

Fri, 20 Jul 2018 11:54:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse
FDA posted a new batch of 43 product-specific guidances related to the development of generic drug products that includes three revised product-specific guidances for ADF opioid products. These guidances recommend specific in vivo studies and in vitro study considerations for abuse deterrence evaluations.

Fri, 20 Jul 2018 11:23:00 -0400


Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA
Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA

Thu, 19 Jul 2018 15:38:00 -0400


Statement by FDA Commissioner Scott Gottlieb, M.D., on the formation of a new work group to develop focused drug importation policy options to address access challenges related to certain sole-source medicines with limited patient availability, but no blocking patents or exclusivities
FDA forms work group on drug importation policy options to address certain patient access challenges

Thu, 19 Jul 2018 07:58:00 -0400


Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings Institution on the release of the FDA’s Biosimilars Action Plan
FDA releases Biosimilars Action Plan to address competition and affordability for biologics and biosimilar products.

Wed, 18 Jul 2018 14:26:00 -0400


FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency

Wed, 18 Jul 2018 10:40:00 -0400


New York-based food processors agree to stop food preparation operations due to food safety violations
New York-based food processors agree to stop food preparation operations due to food safety violations

Tue, 17 Jul 2018 15:19:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D. on new efforts to empower consumers by advancing access to nonprescription drugs
FDA describes innovative approaches to increase access to a broader selection of nonprescription drug products for consumers

Tue, 17 Jul 2018 09:16:00 -0400


FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity
FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure

Fri, 13 Jul 2018 17:35:00 -0400
Diabetes news from the American Diabetes Association

Latest Top (5) News